SLNO
Soleno Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.73B
P/E Ratio
135.28
EPS
$0.39
Beta
-2.81
52W High
$90.32
52W Low
$29.43
50-Day MA
$41.89
200-Day MA
$54.70
Dividend Yield
—
Profit Margin
11.00%
Forward P/E
13.05
PEG Ratio
0.00
About Soleno Therapeutics Inc
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $190.41M |
| Gross Profit (TTM) | $187.71M |
| EBITDA | $16.97M |
| Operating Margin | 44.10% |
| Return on Equity | 6.01% |
| Return on Assets | 2.09% |
| Revenue/Share (TTM) | $3.75 |
| Book Value | $8.61 |
| Price-to-Book | 6.06 |
| Price-to-Sales (TTM) | 14.33 |
| EV/Revenue | 13.0 |
| EV/EBITDA | 87.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $51.72M |
| Float | $47.90M |
| % Insiders | 1.74% |
| % Institutions | 128.13% |
Historical Volatility
HV 10-Day
2.84%
HV 20-Day
107.18%
HV 30-Day
94.27%
HV 60-Day
81.14%
HV Rank
77.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($53.00 target)
2
Strong Buy11
BuyData last updated: 4/29/2026